unknown
Stage
About
arGentis is an early stage biotech company focused on the commercialization of treatments for dry-eye and orphan drugs for systemic sclerosis.
Explore arGentis's full profile on Brouky
Funding rounds, investor list, and risk signals — unlock with a subscription.